Article info

Download PDFPDF
Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity
  1. Correspondence to Prof. Hans-Peter Hammes, 5th Medical Department, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167 Mannheim, Germany; hans-peter.hammes{at}med5.ma.uni-heidelberg.de
View Full Text

Citation

vom Hagen F, Kamppeter BA, Erber R, et al
Intravitreal thalidomide reduces experimental preretinal neovascularisation without induction of retinal toxicity

Publication history

  • Accepted May 25, 2009
  • First published August 27, 2009.
Online issue publication 
April 12, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.